Compare ANIK & USAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIK | USAU |
|---|---|---|
| Founded | 1983 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 200.9M | 214.2M |
| IPO Year | 1996 | 2020 |
| Metric | ANIK | USAU |
|---|---|---|
| Price | $20.86 | $15.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $17.00 | ★ $22.83 |
| AVG Volume (30 Days) | 95.8K | ★ 172.3K |
| Earning Date | 04-29-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.16 | 36.11 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $112,819,000.00 | $17,402,000.00 |
| Revenue This Year | $5.98 | N/A |
| Revenue Next Year | $7.42 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.56 | $12.23 |
| 52 Week High | $22.88 | $23.72 |
| Indicator | ANIK | USAU |
|---|---|---|
| Relative Strength Index (RSI) | 53.85 | 45.24 |
| Support Level | $20.13 | $14.84 |
| Resistance Level | $22.70 | $16.47 |
| Average True Range (ATR) | 0.86 | 0.66 |
| MACD | -0.25 | -0.11 |
| Stochastic Oscillator | 28.81 | 0.90 |
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.
U.S. Gold Corp is a gold, copper and precious metals development and exploration company pursuing exploration opportunities mainly in Wyoming, Nevada and Idaho. It is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada and the Challis Gold Project in Idaho. The company is engaged in the exploration and evaluation of its mineral properties, which is the single operating segment.